Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The syndrome of inappropriate secretion of
antidiuretic hormone
was recognized in a sixty-year-old man with a poorly differentiated metastatic
adenocarcinoma of the prostate
gland. Elevated levels of
antidiuretic hormone
were found in the patient's serum and in the prostatic tumor but not in the cerebrospinal fluid. The patient's clinical course is detailed, and the pathophysiology of this syndrome is discussed.
...
PMID:Prostatic carcinoma producing syndrome of inappropriate secretion of antidiuretic hormone. 117 73
Because small cell anaplastic carcinoma of the prostate is an uncommon tumor, it has remained a poorly defined entity. To elucidate further the clinical, pathological and immunohistochemical characteristics of this cancer the 27 patients who presented to the Mayo Clinic from 1960 to 1990 were reviewed. Of these patients 18 (67%) presented with pure small cell anaplastic carcinoma, and 9 (33%) were diagnosed with small cell anaplastic carcinoma and
adenocarcinoma of the prostate
. Twenty-six patients (96%) had either stage C or D disease at the time of diagnosis. Two patients presented with a paraneoplastic syndrome, including 1 man with inappropriate
antidiuretic hormone
secretion and 1 who suffered from thyroxine intoxication. Of 24 men with long-term followup 22 (92%) died of small cell anaplastic carcinoma of the prostate despite antiandrogen therapy and the remaining 2 are alive with active, progressive disease. The median survival time following diagnosis was 17.1 months (range 2 to 90 months). All tumors with tissue available for immunohistochemical staining reacted positive for neuron-specific enolase, indicating that small cell anaplastic carcinoma of the prostate is most likely a neuroendocrine neoplasm. No tumor stained positive for either prostatic acid phosphatase or prostate specific antigen. Pathologically, small cell anaplastic carcinoma of the prostate appears to be similar to oat cell carcinoma of the lung. This series of 27 patients emphasizes that small cell anaplastic carcinoma of the prostate is highly malignant, is frequently of advanced stage at presentation, responds poorly to antiandrogen therapy and has a poor prognosis.
...
PMID:Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. 131 95
We report the syndrome of inappropriate
antidiuretic hormone
secretion in a 59-year-old man with stage C
adenocarcinoma of the prostate
. Serum
antidiuretic hormone
levels returned to normal following treatment with a gonadotropin-releasing hormone analogue. To our knowledge this case represents the first in which resolution of this syndrome occurred with treatment of the carcinoma.
...
PMID:The syndrome of inappropriate antidiuretic hormone secretion in a patient with adenocarcinoma of the prostate. 834 25
An 88-year-old patient with a poorly differentiated
adenocarcinoma of the prostate
gland was found to have all cardinal findings of syndrome of inappropriate
antidiuretic hormone
secretion (SIADH). Elevated levels of
antidiuretic hormone
were found in the patient's serum and in the prostatic tumor and the cytoplasms of the tumor was positive for prostate specific antigen and was faintly positive for
antidiuretic hormone
(
ADH
). He responded well to combination therapy of androgen blockade with leuprorelin acetate and flutamide, and laboratory findings of SIADH and serum
ADH
level returned to normal. However, he died of sudden profuse bleeding caused by gastric ulcers 6 months after the therapy. Ten cases of SIADH caused by prostatic cancer have been reported including the present case.
...
PMID:Adenocarcinoma of the prostate with ectopic antidiuretic hormone production: a case report. 1096 60
The syndrome of inappropriate secretion of
antidiuretic hormone
(
ADH
) was recognized in a 68-year-old man with a poorly differentiated metastatic
adenocarcinoma of the prostate
. Elevated levels of
ADH
were found in the tissues of the primary tumor and lymph node metastasis. The patient's clinical course is detailed and the pathophysiology of this syndrome is discussed. To our knowledge, this case is the ninth reported case of syndrome of inappropriate secretion of
ADH
with
adenocarcinoma of the prostate
. Antidiuretic hormone activity was proven in only three cases including this case.
...
PMID:Prostate adenocarcinoma producing syndrome of inappropriate secretion of antidiuretic hormone. 1168 74